Regulacje i polityka gospodarcza · 07/12/2000

National Institutes of Health to Grant Exclusive License for Insulin Dependent Diabetes Detection and Treatment

The National Institutes of Health is considering granting an exclusive license to BioSeek Inc. for the use of methods and compositions to detect and treat insulin dependent diabetes, as outlined in US Patent Applications 08548159 and 08542113, filed in 1995 and 1995 respectively.